Reducing the time and cost of clinical tests will help us beat the big killers, then guide our personalised rejuvenation programmes
It's surprising how much pharmaceutical research to date has been more art than science. Computing power is still a long way off predicting the properties of proteins and cells from their DNA, so until then the more research that can be accelerated by automation (e.g. lab robots, lab-on-chip) the better.
And this is being driven by the big pharma companies who can't afford the failure rate at late stage drug development, or worse after release which can result in multi-billion law suits. I attended an excellenty talk by the chief scientific office for GE Healthcare recently and they are mass producing stem cell lines, and the machinery to test them, so that drugs can be tested for cardio-toxicity much earlier on in the development process.
Laboratory Automation News
AI-powered RoboChem for faster, more efficient drug discovery
Interesting Engineering - 25-Jan-2024
Autonomous robot outperforms scientists, accelerating the path to new pharmaceuticalsRead more...
A new method called FAST studies cellular ageing in cultured cells
Live Forever Club - 18-Jan-2024
FAST is precise and works with different cell types and microscopesRead more...
Vivodyne pioneers drug development with lab-grown organs with $38M funding
Longevity Technology - 22-Nov-2023
Offers over 20 innovative organ models for realistic testing and collaboratingRead more...
C. elegans: A tiny worm that can help scientists understand how ageing works
Live Forever Club - 20-Nov-2023
The research could lead to new ways to slow down ageing in humansRead more...
Automata raises $40M to make science labs more efficient and productive
TechCrunch - 03-Oct-2023
Company's LINQ platform streamlines drug development for scientistsRead more...
Laboratory Automation Resources
Click on resource name for more details.